© 2023 GeneDx All rights reserved.
April 3, 2023
GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel
March 20, 2023
GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
March 16, 2023
GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray
March 14, 2023
GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 1, 2023
GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference
February 28, 2023
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
February 21, 2023
GeneDx to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14th, 2023
February 16, 2023
GeneDx Rare Disease Data Demonstrates Utility in Drug Candidate Identification for Common Diseases
January 31, 2023
GeneDx Announces Closing of Underwritten Public Offering and Concurrent Registered Direct Offering
January 30, 2023
GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery
Displaying 21 - 30 of 33
